People channel feed

Sutro slash­es work­force in half, changes CEO and clos­es fac­to­ry

Last month
Pharma
Manufacturing

FDA’s med­ical re­view de­part­ments re­main un­touched (for now) by Musk’s cuts

2 months ago
FDA+

Ex­clu­sive: De­fine Ven­tures hires for­mer Ae­tion CEO Car­olyn Mag­ill

2 months ago
Health Tech

Jeb Keiper steps down from Nim­bus CEO post, busi­ness chief to take over

2 months ago

Roche launch­es new re­search cen­ter with Har­vard in Boston area

2 months ago
R&D

Live up­dates: Makary like­ly a lock for next FDA chief af­ter breezy Sen­ate hear­ing

2 months ago
Pharma
FDA+

Live up­dates: Trump NIH pick Bhat­tacharya sails through Sen­ate hear­ing, side­step­ping con­tro­ver­sy

2 months ago
Pharma
Law

Cere­bral CEO David Mou has stepped down

2 months ago
Health Tech

Phar­ma-backed Mis­sion Ther­a­peu­tics stops pre­clin­i­cal op­er­a­tions, fo­cus­es on two clin­i­cal as­sets

2 months ago
Startups

Can Bill An­der­son save Bay­er?

2 months ago
Pharma
In Focus

Pfiz­er hires ex-FDA deputy Pa­trizia Cavaz­zoni as chief med­ical of­fi­cer

2 months ago
Pharma
FDA+

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

2 months ago
FDA+

Trump’s picks for NIH, CMS say they’ll un­load in­dus­try in­vest­ments

2 months ago
Pharma

Ex­clu­sive: Atom­wise, a once high-fly­ing AI start­up, taps biotech vet as CEO to lead pared-down com­pa­ny

2 months ago
Financing
AI

ARPA-H chief is out as Trump ad­min­is­tra­tion cuts health agen­cies

2 months ago
Pharma

Ko­jin Ther­a­peu­tics shuts down, cit­ing lack of in­vestor in­ter­est and com­plex sci­ence

2 months ago
Startups

Up­dat­ed: Kennedy is con­firmed to lead HHS, putting an­ti-vac­cine ad­vo­cate and drug in­dus­try skep­tic atop US health pro­grams

2 months ago
Pharma

Neumo­ra shakes up C-suite a month af­ter de­pres­sion drug fails first Phase 3 tri­al

2 months ago

New CMO Di­et­mar Berg­er high­lights Gilead’s ‘unique sit­u­a­tion’ and its HIV am­bi­tions

2 months ago
R&D
Pharma

In­ven­ti­va cuts pipeline, lays off near­ly en­tire re­search team in bid to get to Phase 3 MASH read­out

2 months ago
R&D

Ver­tex op­er­a­tions chief Stu­art Ar­buck­le to re­tire

2 months ago
Pharma

Ma­jor FDA staff cuts would slow drug re­views, ex­perts say

3 months ago
FDA+

Up­dat­ed: Bay Area biotech VC to shut down 15 months af­ter launch, sources say, af­ter key in­vestor pulls out

3 months ago
Financing

Pfiz­er hires No­var­tis on­col­o­gy ex­ec to steer its can­cer am­bi­tions

3 months ago
Pharma
First page Previous page 123456 Next page Last page
A service from the Financial Times